EQT makes buy-out offer for Karo Pharma

EQT makes buy-out offer for Karo Pharma

Sweden-based private equity fund EQT said it had made a cash offer for the remaining shares in Swedish biopharmaceuticals group Karo Pharma. EQT currently owns 86% of Karo Pharma. The total value of the offer is $215.15m, valuing Karo Pharma at $1.6bn, EQT subsidiary...